Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host

Andy Alhassan, Huitao Liu, Jodi McGill, Argine Cerezo, Laxmi U.M.R. Jakkula, Arathy D.S. Nair, Emma Winkley, Sally Olson, Denver Marlow, Abha Sahni, Hema P. Narra, Sanjeev Sahni, Jamie Henningson, Roman R. Ganta

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rocky Mountain spotted fever (RMSF) is a potentially fatal tick-borne disease in people and dogs. RMSF is reported in the United States and several countries in North, Central, and South America. The causative agent of this disease, Rickettsia rickettsii, is transmitted by several species of ticks, including Dermacentor andersoni, Rhipicephalus sanguineus, and Amblyomma americanum RMSF clinical signs generally include fever, headache, nausea, vomiting, muscle pain, lack of appetite, and rash. If untreated, it can quickly progress into a life-threatening illness in people and dogs, with high fatality rates ranging from 30 to 80%. While RMSF has been known for over a century, recent epidemiological data suggest that the numbers of documented cases and the fatality rates remain high in people, particularly during the last two decades in parts of North America. Currently, there are no vaccines available to prevent RMSF in either dogs or people. In this study, we investigated the efficacies of two experimental vaccines, a subunit vaccine containing two recombinant outer membrane proteins as recombinant antigens (RCA) and a whole-cell inactivated antigen vaccine (WCA), in conferring protection against virulent R. rickettsii infection challenge in a newly established canine model for RMSF. Dogs vaccinated with WCA were protected from RMSF, whereas those receiving RCA developed disease similar to that of nonvaccinated R. rickettsii-infected dogs. WCA also reduced the pathogen loads to nearly undetected levels in the blood, lungs, liver, spleen, and brain and induced bacterial antigen-specific immune responses. This study provides the first evidence of the protective ability of WCA against RMSF in dogs.

Original languageEnglish (US)
JournalInfection and Immunity
Volume87
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Rickettsia rickettsii
Rocky Mountain Spotted Fever
Canidae
Antigens
Dogs
North America
Rickettsia Infections
Vaccines
Rhipicephalus sanguineus
Dermacentor
Tick-Borne Diseases
Bacterial Antigens
Central America
Inactivated Vaccines
Subunit Vaccines
Aptitude
South America
Myalgia
Ticks
Appetite

Keywords

  • Rickettsia
  • RMSF
  • Rocky Mountain spotted fever
  • tick-borne pathogens
  • vaccines
  • vector-borne diseases

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases

Cite this

Alhassan, A., Liu, H., McGill, J., Cerezo, A., Jakkula, L. U. M. R., Nair, A. D. S., ... Ganta, R. R. (2019). Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host. Infection and Immunity, 87(2). https://doi.org/10.1128/IAI.00628-18

Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host. / Alhassan, Andy; Liu, Huitao; McGill, Jodi; Cerezo, Argine; Jakkula, Laxmi U.M.R.; Nair, Arathy D.S.; Winkley, Emma; Olson, Sally; Marlow, Denver; Sahni, Abha; Narra, Hema P.; Sahni, Sanjeev; Henningson, Jamie; Ganta, Roman R.

In: Infection and Immunity, Vol. 87, No. 2, 01.02.2019.

Research output: Contribution to journalArticle

Alhassan, A, Liu, H, McGill, J, Cerezo, A, Jakkula, LUMR, Nair, ADS, Winkley, E, Olson, S, Marlow, D, Sahni, A, Narra, HP, Sahni, S, Henningson, J & Ganta, RR 2019, 'Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host', Infection and Immunity, vol. 87, no. 2. https://doi.org/10.1128/IAI.00628-18
Alhassan, Andy ; Liu, Huitao ; McGill, Jodi ; Cerezo, Argine ; Jakkula, Laxmi U.M.R. ; Nair, Arathy D.S. ; Winkley, Emma ; Olson, Sally ; Marlow, Denver ; Sahni, Abha ; Narra, Hema P. ; Sahni, Sanjeev ; Henningson, Jamie ; Ganta, Roman R. / Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host. In: Infection and Immunity. 2019 ; Vol. 87, No. 2.
@article{c17f6c76636c492cb31263418b4d2ffe,
title = "Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host",
abstract = "Rocky Mountain spotted fever (RMSF) is a potentially fatal tick-borne disease in people and dogs. RMSF is reported in the United States and several countries in North, Central, and South America. The causative agent of this disease, Rickettsia rickettsii, is transmitted by several species of ticks, including Dermacentor andersoni, Rhipicephalus sanguineus, and Amblyomma americanum RMSF clinical signs generally include fever, headache, nausea, vomiting, muscle pain, lack of appetite, and rash. If untreated, it can quickly progress into a life-threatening illness in people and dogs, with high fatality rates ranging from 30 to 80{\%}. While RMSF has been known for over a century, recent epidemiological data suggest that the numbers of documented cases and the fatality rates remain high in people, particularly during the last two decades in parts of North America. Currently, there are no vaccines available to prevent RMSF in either dogs or people. In this study, we investigated the efficacies of two experimental vaccines, a subunit vaccine containing two recombinant outer membrane proteins as recombinant antigens (RCA) and a whole-cell inactivated antigen vaccine (WCA), in conferring protection against virulent R. rickettsii infection challenge in a newly established canine model for RMSF. Dogs vaccinated with WCA were protected from RMSF, whereas those receiving RCA developed disease similar to that of nonvaccinated R. rickettsii-infected dogs. WCA also reduced the pathogen loads to nearly undetected levels in the blood, lungs, liver, spleen, and brain and induced bacterial antigen-specific immune responses. This study provides the first evidence of the protective ability of WCA against RMSF in dogs.",
keywords = "Rickettsia, RMSF, Rocky Mountain spotted fever, tick-borne pathogens, vaccines, vector-borne diseases",
author = "Andy Alhassan and Huitao Liu and Jodi McGill and Argine Cerezo and Jakkula, {Laxmi U.M.R.} and Nair, {Arathy D.S.} and Emma Winkley and Sally Olson and Denver Marlow and Abha Sahni and Narra, {Hema P.} and Sanjeev Sahni and Jamie Henningson and Ganta, {Roman R.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1128/IAI.00628-18",
language = "English (US)",
volume = "87",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host

AU - Alhassan, Andy

AU - Liu, Huitao

AU - McGill, Jodi

AU - Cerezo, Argine

AU - Jakkula, Laxmi U.M.R.

AU - Nair, Arathy D.S.

AU - Winkley, Emma

AU - Olson, Sally

AU - Marlow, Denver

AU - Sahni, Abha

AU - Narra, Hema P.

AU - Sahni, Sanjeev

AU - Henningson, Jamie

AU - Ganta, Roman R.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Rocky Mountain spotted fever (RMSF) is a potentially fatal tick-borne disease in people and dogs. RMSF is reported in the United States and several countries in North, Central, and South America. The causative agent of this disease, Rickettsia rickettsii, is transmitted by several species of ticks, including Dermacentor andersoni, Rhipicephalus sanguineus, and Amblyomma americanum RMSF clinical signs generally include fever, headache, nausea, vomiting, muscle pain, lack of appetite, and rash. If untreated, it can quickly progress into a life-threatening illness in people and dogs, with high fatality rates ranging from 30 to 80%. While RMSF has been known for over a century, recent epidemiological data suggest that the numbers of documented cases and the fatality rates remain high in people, particularly during the last two decades in parts of North America. Currently, there are no vaccines available to prevent RMSF in either dogs or people. In this study, we investigated the efficacies of two experimental vaccines, a subunit vaccine containing two recombinant outer membrane proteins as recombinant antigens (RCA) and a whole-cell inactivated antigen vaccine (WCA), in conferring protection against virulent R. rickettsii infection challenge in a newly established canine model for RMSF. Dogs vaccinated with WCA were protected from RMSF, whereas those receiving RCA developed disease similar to that of nonvaccinated R. rickettsii-infected dogs. WCA also reduced the pathogen loads to nearly undetected levels in the blood, lungs, liver, spleen, and brain and induced bacterial antigen-specific immune responses. This study provides the first evidence of the protective ability of WCA against RMSF in dogs.

AB - Rocky Mountain spotted fever (RMSF) is a potentially fatal tick-borne disease in people and dogs. RMSF is reported in the United States and several countries in North, Central, and South America. The causative agent of this disease, Rickettsia rickettsii, is transmitted by several species of ticks, including Dermacentor andersoni, Rhipicephalus sanguineus, and Amblyomma americanum RMSF clinical signs generally include fever, headache, nausea, vomiting, muscle pain, lack of appetite, and rash. If untreated, it can quickly progress into a life-threatening illness in people and dogs, with high fatality rates ranging from 30 to 80%. While RMSF has been known for over a century, recent epidemiological data suggest that the numbers of documented cases and the fatality rates remain high in people, particularly during the last two decades in parts of North America. Currently, there are no vaccines available to prevent RMSF in either dogs or people. In this study, we investigated the efficacies of two experimental vaccines, a subunit vaccine containing two recombinant outer membrane proteins as recombinant antigens (RCA) and a whole-cell inactivated antigen vaccine (WCA), in conferring protection against virulent R. rickettsii infection challenge in a newly established canine model for RMSF. Dogs vaccinated with WCA were protected from RMSF, whereas those receiving RCA developed disease similar to that of nonvaccinated R. rickettsii-infected dogs. WCA also reduced the pathogen loads to nearly undetected levels in the blood, lungs, liver, spleen, and brain and induced bacterial antigen-specific immune responses. This study provides the first evidence of the protective ability of WCA against RMSF in dogs.

KW - Rickettsia

KW - RMSF

KW - Rocky Mountain spotted fever

KW - tick-borne pathogens

KW - vaccines

KW - vector-borne diseases

UR - http://www.scopus.com/inward/record.url?scp=85060511806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060511806&partnerID=8YFLogxK

U2 - 10.1128/IAI.00628-18

DO - 10.1128/IAI.00628-18

M3 - Article

VL - 87

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 2

ER -